A Study of the Efficacy and Safety of Supaglutide in Healthy Participants
Status:
Completed
Trial end date:
2019-12-13
Target enrollment:
Participant gender:
Summary
This study is to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of
the investigational drug Supaglutide proposed dosing once (or twice) weekly in Chinese
healthy subjects.
Linking Truth Technology Co., Ltd. Medidata Solutions Mosim Co., Ltd. The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School Tigermed Consulting Co., Ltd